Predictive Oncology plans to raise approximately $344 million through a share offering to support the launch of the Aethir (ATH) treasury.
Jinse Finance reported that Nasdaq-listed company Predictive Oncology announced plans to raise approximately $344 million through two private investment in public equity (PIPE) offerings to support the launch of the Aethir (ATH) treasury. It is reported that DNA Holdings Venture, Inc. will serve as the strategic advisor for the digital currency treasury and the company's digital asset financial advisor.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Aster: S2 phase rewards can be chosen as "full refund of transaction fees" option
A certain whale invested $2.92 million to purchase 1.69 million ASTER.
The probability of the Federal Reserve cutting interest rates by 25 basis points in October is as high as 94.6%.
BlackRock IBIT holdings valued at approximately $96 billion
